The Michelson Medical Research Foundation (MMRF), together with the Human Vaccines Project, established the Michelson Prizes: Next Generation Grants in 2017. This $20 million initiative supports research proposals from young investigators who are using disruptive research concepts and inventive processes to significantly advance the development of vaccines and immunotherapies for major global diseases.
The 2022 Michelson Prizes is accepting applications related to Human Immunology and Vaccine Research, including research aimed at tackling the current roadblocks in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development (e.g., immune memory, immune receptor recognition, tissue- specific responses, host-microbe interactions, underlying genetic mechanisms, genetic susceptibility, etc.).
The Michelson Prizes are intended to support individuals early in their careers who possess novel ideas and who have significant potential to execute these ideas to affect transformative change in their respective fields. Research should incorporate multiplexed and non-traditional approaches from outside the fields of immunology and vaccinology and demonstrate a high degree of novelty and creative thinking. The successful applicants will clearly articulate a vision that challenges current dogma and demonstrates an ability to look beyond convention to make a lasting impact on vaccine and immunotherapy research.